Alexa Sengupta is an associate at the firm's Nashville office. She is a member of the Health Care and FDA practice group.
She focuses her practice on both health care and FDA regulatory matters, advising clients on requirements related to medical devices, pharmaceuticals, and biologics, as well as cosmetics and dietary supplements.
Alexa also has experience assisting with federal and state healthcare regulatory and compliance matters, including: fraud and abuse concerns relating to the Stark law, Anti-kickback Statute, and False Claims Act; Medicare enrollment-related issues; and health care state licensure and day-to-day operational issues.
Alexa also assists in the execution of corporate transactions, particularly focusing on health care clients, by advising clients through mergers and acquisitions, strategic collaborations, and joint ventures.
Prior to joining the firm, Alexa served as a corporate health care associate at a U.S. law firm, where she counseled organizations regarding health care regulatory compliance and operational matters and assisted in corporate transactions.